Trials / Completed
CompletedNCT06887972
A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries
A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Aesthetic or Reconstructive Surgeries
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study to evaluate the effectiveness, safety, and tolerability of SUZ as part of multimodal therapy (MMT) in treating acute postoperative pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Suzetrigine | Tablets for oral administration. |
Timeline
- Start date
- 2025-03-21
- Primary completion
- 2025-10-24
- Completion
- 2025-11-07
- First posted
- 2025-03-21
- Last updated
- 2025-12-15
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06887972. Inclusion in this directory is not an endorsement.